BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G, Libra M. Gut Microbiota and Cancer: From Pathogenesis to Therapy. Cancers (Basel) 2019;11:E38. [PMID: 30609850 DOI: 10.3390/cancers11010038] [Cited by in Crossref: 250] [Cited by in F6Publishing: 264] [Article Influence: 62.5] [Reference Citation Analysis]
Number Citing Articles
1 Poto R, Laniro G, de Paulis A, Spadaro G, Marone G, Gasbarrini A, Varricchi G. Is there a role for microbiome-based approach in common variable immunodeficiency? Clin Exp Med 2023;:1-18. [PMID: 36737487 DOI: 10.1007/s10238-023-01006-3] [Reference Citation Analysis]
2 Deng R, Zhang H, Li Y, Shi Y. Effect of Antacid Use on Immune Checkpoint Inhibitors in Advanced Solid Cancer Patients: A Systematic Review and Meta-analysis. J Immunother 2023;46:43-55. [PMID: 36301729 DOI: 10.1097/CJI.0000000000000442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 McKay MJ, Castaneda M, Catania S, Charles KA, Shanahan E, Clarke SJ, Engel A, Varelis P, Molloy MP. Quantification of short-chain fatty acids in human stool samples by LC-MS/MS following derivatization with aniline analogues. J Chromatogr B Analyt Technol Biomed Life Sci 2023;1217:123618. [PMID: 36731355 DOI: 10.1016/j.jchromb.2023.123618] [Reference Citation Analysis]
4 Yue S, Zhang Z, Bian F, Zhang Y, Chen G, Zhu Y, Li J, Picimbon J. 3L, three-Lactobacilli on recovering of microbiome and immune-damage by cyclophosphamide chemotherapy —A pilot experiment in rats—.. [DOI: 10.21203/rs.3.rs-2451339/v1] [Reference Citation Analysis]
5 Álvarez-Mercado AI, Del Valle Cano A, Fernández MF, Fontana L. Gut Microbiota and Breast Cancer: The Dual Role of Microbes. Cancers (Basel) 2023;15. [PMID: 36672391 DOI: 10.3390/cancers15020443] [Reference Citation Analysis]
6 Muthusamy M, Ramani P, Poothakulath Krishnan R, K H, Sukumaran G, Ramasubramanian A. Oral Microflora and Its Potential Carcinogenic Effect on Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Cureus 2023. [DOI: 10.7759/cureus.33560] [Reference Citation Analysis]
7 Khaleel SM, Shanshal SA, Khalaf MM. The Role of Probiotics in Colorectal Cancer: A Review. J Gastrointest Cancer 2023. [PMID: 36622515 DOI: 10.1007/s12029-022-00903-2] [Reference Citation Analysis]
8 Yue S, Zhang Z, Bian F, Zhang Y, Chen G, Zhu Y, Li J, Picimbon J. 3L, three-Lactobacilli on recovering of microbiome and immune-damage by cyclophosphamide chemotherapy —A pilot experiment—.. [DOI: 10.21203/rs.3.rs-2423168/v1] [Reference Citation Analysis]
9 Yang HJ, Kim JH. Role of microbiome and its metabolite, short chain fatty acid in prostate cancer. Investig Clin Urol 2023;64:3-12. [PMID: 36629060 DOI: 10.4111/icu.20220370] [Reference Citation Analysis]
10 Mbatha SZ, Mkhize-kwitshana ZL, Mulaudzi TV, Hull R, Dlamini Z. Artificial Intelligence Application to Microbiomics Data for Improved Clinical Decision Making in Precision Oncology. Artificial Intelligence and Precision Oncology 2023. [DOI: 10.1007/978-3-031-21506-3_8] [Reference Citation Analysis]
11 Greco G, Zeppa SD, Agostini D, Attisani G, Stefanelli C, Ferrini F, Sestili P, Fimognari C. The Anti- and Pro-Tumorigenic Role of Microbiota and Its Role in Anticancer Therapeutic Strategies. Cancers (Basel) 2022;15. [PMID: 36612186 DOI: 10.3390/cancers15010190] [Reference Citation Analysis]
12 Pheeha SM, Tamuzi JL, Manda S, Nyasulu PS. Identifying Gut Microbiota Conditions Associated with Disease in the African Continent: A Scoping Review Protocol. Methods Protoc 2022;6:2. [PMID: 36648951 DOI: 10.3390/mps6010002] [Reference Citation Analysis]
13 Campisciano G, Biffi S. Microbiota in vivo imaging approaches to study host-microbe interactions in preclinical and clinical setting. Heliyon 2022;8:e12511. [PMID: 36593827 DOI: 10.1016/j.heliyon.2022.e12511] [Reference Citation Analysis]
14 Begum N, Mandhare A, Tryphena KP, Srivastava S, Shaikh MF, Singh SB, Khatri DK. Epigenetics in depression and gut-brain axis: A molecular crosstalk. Front Aging Neurosci 2022;14:1048333. [PMID: 36583185 DOI: 10.3389/fnagi.2022.1048333] [Reference Citation Analysis]
15 Ibrahim I, Syamala S, Ayariga JA, Xu J, Robertson BK, Meenakshisundaram S, Ajayi OS. Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids. Metabolites 2022;12. [PMID: 36557285 DOI: 10.3390/metabo12121247] [Reference Citation Analysis]
16 Loganathan T, Priya Doss C G. The influence of machine learning technologies in gut microbiome research and cancer studies - A review. Life Sciences 2022;311:121118. [DOI: 10.1016/j.lfs.2022.121118] [Reference Citation Analysis]
17 Ortega M, García-montero C, Fraile-martínez O, Monserrat J, Álvarez-mon M. La microbiota intestinal en la salud y en la enfermedad. Medicine - Programa de Formación Médica Continuada Acreditado 2022;13:4054-4063. [DOI: 10.1016/j.med.2022.12.003] [Reference Citation Analysis]
18 Corrie L, Gulati M, Awasthi A, Vishwas S, Kaur J, Khursheed R, Kumar R, Kumar A, Imran M, Chellappan D, Gupta G, de Jesus Andreoli Pinto T, Morris A, Choonara Y, Adams J, Dua K, Singh S. Polysaccharide, fecal microbiota, and curcumin-based novel oral colon-targeted solid self-nanoemulsifying delivery system: formulation, characterization, and in-vitro anticancer evaluation. Materials Today Chemistry 2022;26:101165. [DOI: 10.1016/j.mtchem.2022.101165] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Effendi RMRA, Anshory M, Kalim H, Dwiyana RF, Suwarsa O, Pardo LM, Nijsten TEC, Thio HB. Akkermansia muciniphila and Faecalibacterium prausnitzii in Immune-Related Diseases. Microorganisms 2022;10. [PMID: 36557635 DOI: 10.3390/microorganisms10122382] [Reference Citation Analysis]
20 Wei YF, Huang MS, Huang CH, Yeh YT, Hung CH. Impact of Gut Dysbiosis on the Risk of Non-Small-Cell Lung Cancer. Int J Environ Res Public Health 2022;19. [PMID: 36498063 DOI: 10.3390/ijerph192315991] [Reference Citation Analysis]
21 Yu I, Wu R, Tokumaru Y, Terracina KP, Takabe K. The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer. Cancers (Basel) 2022;14. [PMID: 36428777 DOI: 10.3390/cancers14225685] [Reference Citation Analysis]
22 Dacrema M, Ali A, Ullah H, Khan A, Di Minno A, Xiao J, Martins AMC, Daglia M. Spice-Derived Bioactive Compounds Confer Colorectal Cancer Prevention via Modulation of Gut Microbiota. Cancers (Basel) 2022;14. [PMID: 36428774 DOI: 10.3390/cancers14225682] [Reference Citation Analysis]
23 Wen X, Ye X, Yang X, Jiang R, Qian C, Wang X. The crosstalk between intestinal bacterial microbiota and immune cells in colorectal cancer progression. Clin Transl Oncol 2022. [DOI: 10.1007/s12094-022-02995-5] [Reference Citation Analysis]
24 Erdogan K, Isik M, Barut D, Sengel-turk CT, Amasya G, Derkus B, Cabuk A, Celik PA. Capecitabine-loaded Bacterial Membrane Vesicles Derived from Enterococcus faecalis Promotes Apoptosis in HT-29 Colon Cancer Cells. Biochemical Engineering Journal 2022. [DOI: 10.1016/j.bej.2022.108722] [Reference Citation Analysis]
25 Yue S, Zhang Z, Bian F, Zhang Y, Chen G, Zhu Y, Li J, Picimbon J. 3L, three-Lactobacilli on recovering of microbiome and immune-damage by cyclophosphamide chemotherapy.. [DOI: 10.21203/rs.3.rs-2113752/v1] [Reference Citation Analysis]
26 Afzaal M, Saeed F, Shah YA, Hussain M, Rabail R, Socol CT, Hassoun A, Pateiro M, Lorenzo JM, Rusu AV, Aadil RM. Human gut microbiota in health and disease: Unveiling the relationship. Front Microbiol 2022;13:999001. [DOI: 10.3389/fmicb.2022.999001] [Reference Citation Analysis]
27 Cheng X, Wang J, Gong L, Dong Y, Shou J, Pan H, Yu Z, Fang Y. Composition of the Gut Microbiota Associated with the Response to Immunotherapy in Advanced Cancer Patients: A Chinese Real-World Pilot Study. J Clin Med 2022;11:5479. [PMID: 36143126 DOI: 10.3390/jcm11185479] [Reference Citation Analysis]
28 Syromyatnikov M, Nesterova E, Gladkikh M, Smirnova Y, Gryaznova M, Popov V. Characteristics of the Gut Bacterial Composition in People of Different Nationalities and Religions. Microorganisms 2022;10:1866. [PMID: 36144468 DOI: 10.3390/microorganisms10091866] [Reference Citation Analysis]
29 Zhou B, Wang C, Putzel G, Hu J, Liu M, Wu F, Chen Y, Pironti A, Li H. An integrated strain-level analytic pipeline utilizing longitudinal metagenomic data.. [DOI: 10.21203/rs.3.rs-2050142/v1] [Reference Citation Analysis]
30 Wojciechowski S, Majchrzak-Górecka M, Biernat P, Odrzywołek K, Pruss Ł, Zych K, Jan Majta, Milanowska-Zabel K. Machine learning on the road to unlocking microbiota's potential for boosting immune checkpoint therapy. Int J Med Microbiol 2022;312:151560. [PMID: 36113358 DOI: 10.1016/j.ijmm.2022.151560] [Reference Citation Analysis]
31 Álvarez-mercado AI, Sáez-lara MJ, Plaza-diaz J. Editorial: Molecular and cellular aspects of regulatory and subjacent mechanisms in host/microbiota association and its involvement in cancer. Front Cell Dev Biol 2022;10:989208. [DOI: 10.3389/fcell.2022.989208] [Reference Citation Analysis]
32 Wu H, Ganguly S, Tollefsbol TO. Modulating Microbiota as a New Strategy for Breast Cancer Prevention and Treatment. Microorganisms 2022;10:1727. [DOI: 10.3390/microorganisms10091727] [Reference Citation Analysis]
33 Yang S, Zhao S, Ye Y, Jia L, Lou Y. Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021). Front Immunol 2022;13:952546. [DOI: 10.3389/fimmu.2022.952546] [Reference Citation Analysis]
34 Boulaka A, Mantellou P, Stanc G, Souka E, Valavanis C, Saxami G, Mitsou E, Koutrotsios G, Zervakis GI, Kyriacou A, Pletsa V, Georgiadis P. Genoprotective activity of the Pleurotus eryngii mushrooms following their in vitro and in vivo fermentation by fecal microbiota. Front Nutr 2022;9:988517. [DOI: 10.3389/fnut.2022.988517] [Reference Citation Analysis]
35 Hasavci D, Blank T. Age-dependent effects of gut microbiota metabolites on brain resident macrophages. Front Cell Neurosci 2022;16:944526. [DOI: 10.3389/fncel.2022.944526] [Reference Citation Analysis]
36 Ying H, Xie W, Wang M, He J, Zhang H, Yu C. Gut microbiota: An emerging therapeutic approach of herbal medicine for prevention of colorectal cancer. Front Cell Infect Microbiol 2022;12:969526. [DOI: 10.3389/fcimb.2022.969526] [Reference Citation Analysis]
37 Fakharian F, Asgari B, Nabavi-rad A, Sadeghi A, Soleimani N, Yadegar A, Zali MR. The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis. Front Cell Infect Microbiol 2022;12:953718. [DOI: 10.3389/fcimb.2022.953718] [Reference Citation Analysis]
38 Jalandra R, Dhar R, Pethusamy K, Sharma M, Karmakar S. Dysbiosis: Gut feeling. F1000Res 2022;11:911. [DOI: 10.12688/f1000research.122429.1] [Reference Citation Analysis]
39 Ehrenworth Breedon AM, Beabout KR, Coia HG, Davis CM, Harbaugh SV, Mauzy CA, Nelson MT, Saldanha RJ, Stamps BW, Goodson MS. Biological Sensors for Microbiome Diagnostics. Principles in Microbiome Engineering 2022. [DOI: 10.1002/9783527825462.ch6] [Reference Citation Analysis]
40 Dong Z, Shen X, Hao Y, Li J, Xu H, Yin L, Kuang W. Gut microbiome: A potential indicator for predicting treatment outcomes in major depressive disorder. Front Neurosci 2022;16:813075. [DOI: 10.3389/fnins.2022.813075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Qin H, Yuan B, Huang W, Wang Y. Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances. Front Oncol 2022;12:924696. [DOI: 10.3389/fonc.2022.924696] [Reference Citation Analysis]
42 Ragone C, Manolio C, Mauriello A, Cavalluzzo B, Buonaguro FM, Tornesello ML, Tagliamonte M, Buonaguro L. Molecular mimicry between tumor associated antigens and microbiota-derived epitopes. J Transl Med 2022;20:316. [PMID: 35836198 DOI: 10.1186/s12967-022-03512-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Zhao H, Chen X, Zhang L, Meng F, Zhou L, Pang X, Lu Z, Lu Y. Lacticaseibacillus rhamnosus Fmb14 prevents purine induced hyperuricemia and alleviate renal fibrosis through gut-kidney axis. Pharmacol Res 2022;182:106350. [PMID: 35843568 DOI: 10.1016/j.phrs.2022.106350] [Reference Citation Analysis]
44 Wang M, Yu F. Research Progress on the Anticancer Activities and Mechanisms of Polysaccharides From Ganoderma. Front Pharmacol 2022;13:891171. [DOI: 10.3389/fphar.2022.891171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Li Y, Jiang H, Wang X, Liu X, Huang Y, Wang Z, Ma Q, Dong L, Qi Y, Zhang H, Lu G. Crosstalk Between the Gut and Brain: Importance of the Fecal Microbiota in Patient With Brain Tumors. Front Cell Infect Microbiol 2022;12:881071. [DOI: 10.3389/fcimb.2022.881071] [Reference Citation Analysis]
46 Lingas EC. Empiric Antibiotics in COVID 19: A Narrative Review. Cureus 2022. [DOI: 10.7759/cureus.25596] [Reference Citation Analysis]
47 Dar S, Merza N, Qatani A, Rahim M, Varughese T, Mohammad A, Masood F, Reza FZ, Wan S, Almas T. Impact of proton-pump inhibitors on the efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis. Annals of Medicine and Surgery 2022;78:103752. [DOI: 10.1016/j.amsu.2022.103752] [Reference Citation Analysis]
48 Giron M, Thomas M, Dardevet D, Chassard C, Savary-Auzeloux I. Gut microbes and muscle function: can probiotics make our muscles stronger? J Cachexia Sarcopenia Muscle 2022;13:1460-76. [PMID: 35278043 DOI: 10.1002/jcsm.12964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
49 Sampsell K, Wang W, Ohland C, Mager LF, Pett N, Lowry DE, Sales KM, McNeely ML, McCoy KD, Culos-Reed SN, Reimer RA. Exercise and Prebiotic Fiber Provide Gut Microbiota-Driven Benefit in a Survivor to Germ-Free Mouse Translational Model of Breast Cancer. Cancers (Basel) 2022;14:2722. [PMID: 35681702 DOI: 10.3390/cancers14112722] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Dey P, Ray Chaudhuri S. Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches. Biology 2022;11:757. [DOI: 10.3390/biology11050757] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
51 Said I, Ahad H, Said A. Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics. World J Gastrointest Oncol 2022; 14(5): 947-958 [DOI: 10.4251/wjgo.v14.i5.947] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Dikeocha IJ, Al-kabsi AM, Chiu H, Alshawsh MA. Faecalibacterium prausnitzii Ameliorates Colorectal Tumorigenesis and Suppresses Proliferation of HCT116 Colorectal Cancer Cells. Biomedicines 2022;10:1128. [DOI: 10.3390/biomedicines10051128] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
53 Meng Z, Ye Z, Zhu P, Zhu J, Fang S, Qiu T, Li Y, Meng L. New Developments and Opportunities of Microbiota in Treating Breast Cancers. Front Microbiol 2022;13:818793. [DOI: 10.3389/fmicb.2022.818793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Lee SHF, Ahmad SR, Lim YC, Zulkipli IN. The Use of Probiotic Therapy in Metabolic and Neurological Diseases. Front Nutr 2022;9:887019. [DOI: 10.3389/fnut.2022.887019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Glyn T, Purcell R. Circulating Bacterial DNA: A New Paradigm for Cancer Diagnostics. Front Med (Lausanne) 2022;9:831096. [PMID: 35445046 DOI: 10.3389/fmed.2022.831096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Campbell CD, Barnett C, Sulaiman I. A clinicians’ review of the respiratory microbiome. Breathe 2022;18:210161. [DOI: 10.1183/20734735.0161-2021] [Reference Citation Analysis]
57 Jianqing W, Ping Z. Clinical trials cannot provide sufficient accuracy for studying weak factors necessary for curing chronic diseases. Glob J Cancer Ther 2022;8:021-033. [DOI: 10.17352/2581-5407.000044] [Reference Citation Analysis]
58 Vijayakumar M, Priya K, Tharmalingam N, Bose RJC, Madheswaran T, Ramasamy M. Bacteria therapeutics for cancer oncology: a crossroads for new paradigms. Drug Discov Today 2022:S1359-6446(22)00115-5. [PMID: 35304339 DOI: 10.1016/j.drudis.2022.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Li Y, Ye Z, Zhu J, Fang S, Meng L, Zhou C. Effects of Gut Microbiota on Host Adaptive Immunity Under Immune Homeostasis and Tumor Pathology State. Front Immunol 2022;13:844335. [DOI: 10.3389/fimmu.2022.844335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Ahmed H, Hamad S, Shedeed HA, Saad A. Review of Personalized Cancer Treatment with Machine Learning. 2022 5th International Conference on Computing and Informatics (ICCI) 2022. [DOI: 10.1109/icci54321.2022.9756124] [Reference Citation Analysis]
61 Giambò F, Costa C, Teodoro M, Fenga C. Role-Playing Between Environmental Pollutants and Human Gut Microbiota: A Complex Bidirectional Interaction. Front Med (Lausanne) 2022;9:810397. [PMID: 35252248 DOI: 10.3389/fmed.2022.810397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Bu W, Dong G, Da W, Zhang G, Liu H, Ju X, Li R, Yuan B. Salvianolic acid-modified chitosan particle for shift intestinal microbiota composition and metabolism to reduce benzopyrene toxicity for mice. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103262] [Reference Citation Analysis]
63 Akbar N, Khan NA, Muhammad JS, Siddiqui R. The role of gut microbiome in cancer genesis and cancer prevention. Health Sciences Review 2022;2:100010. [DOI: 10.1016/j.hsr.2021.100010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Zhou B, Wang C, Putzel G, Hu J, Liu M, Wu F, Chen Y, Pironti A, Li H. An integrated strain-level analytic pipeline utilizing longitudinal metagenomic data.. [DOI: 10.1101/2022.02.15.480548] [Reference Citation Analysis]
65 Zhao H, Lu Z, Lu Y. The potential of probiotics in the amelioration of hyperuricemia. Food Funct 2022. [PMID: 35156670 DOI: 10.1039/d1fo03206b] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
66 Zyoud SH, Al-Jabi SW, Amer R, Shakhshir M, Shahwan M, Jairoun AA, Akkawi M, Abu Taha A. Global research trends on the links between the gut microbiome and cancer: a visualization analysis. J Transl Med 2022;20:83. [PMID: 35148757 DOI: 10.1186/s12967-022-03293-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
67 Fu J, Yu M, Xu W, Yu S. Research Progress of Bile Acids in Cancer. Front Oncol 2022;11:778258. [DOI: 10.3389/fonc.2021.778258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
68 Zafar H, Saier MH Jr. Gut Bacteroides species in health and disease. Gut Microbes 2021;13:1-20. [PMID: 33535896 DOI: 10.1080/19490976.2020.1848158] [Cited by in Crossref: 106] [Cited by in F6Publishing: 102] [Article Influence: 106.0] [Reference Citation Analysis]
69 Yang L, Sun J, Zhao M, Xi B. Chili pepper intake and all-cause and disease-specific mortality. Int J Vitam Nutr Res 2022. [PMID: 35038885 DOI: 10.1024/0300-9831/a000746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Melim C, Lauro MR, Pires IM, Oliveira PJ, Cabral C. The Role of Glucosinolates from Cruciferous Vegetables (Brassicaceae) in Gastrointestinal Cancers: From Prevention to Therapeutics. Pharmaceutics 2022;14:190. [PMID: 35057085 DOI: 10.3390/pharmaceutics14010190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
71 Thrastardottir TO, Copeland VJ, Constantinou C. The Association Between the Gut Microbiome, Nutritional Habits, Antibiotics, and Gastric Cancer: a Scoping Review. Curr Nutr Rep 2022. [PMID: 35020173 DOI: 10.1007/s13668-021-00391-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Pfister CA, Light SH, Bohannan B, Schmidt T, Martiny A, Hynson NA, Devkota S, David L, Whiteson K. Conceptual Exchanges for Understanding Free-Living and Host-Associated Microbiomes. mSystems 2022;:e0137421. [PMID: 35014872 DOI: 10.1128/msystems.01374-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Sankarapandian V, Venmathi Maran BA, Rajendran RL, Jogalekar MP, Gurunagarajan S, Krishnamoorthy R, Gangadaran P, Ahn BC. An Update on the Effectiveness of Probiotics in the Prevention and Treatment of Cancer. Life (Basel) 2022;12:59. [PMID: 35054452 DOI: 10.3390/life12010059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
74 Zeuner A, De Angelis ML, Francescangeli F. Gut Microbiota and Colorectal Cancer. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00029-2] [Reference Citation Analysis]
75 Curioni CC, da Silva ACF, da Silva Pereira A, Mocellin MC. The Role of Dietary Habits on Development and Progress of Risk Factors of Chronic Non-communicable Diseases. Integrated Science 2022. [DOI: 10.1007/978-3-030-85357-0_5] [Reference Citation Analysis]
76 Sevcikova A, Izoldova N, Stevurkova V, Kasperova B, Chovanec M, Ciernikova S, Mego M. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy. Int J Mol Sci 2022;23:488. [PMID: 35008915 DOI: 10.3390/ijms23010488] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
77 Devika Das J, Akhila VS, Paul M, Shankar A, Joseph I, Thomas S. Modern Perspectives in Controlling Human Diseases through Probiotic Intervention. Human Microbiome 2022. [DOI: 10.1007/978-981-16-7672-7_8] [Reference Citation Analysis]
78 Ahlawat S, Asha, Sharma KK. Cancer therapeutics and gut microflora. Microbial Crosstalk with Immune System 2022. [DOI: 10.1016/b978-0-323-96128-8.00005-5] [Reference Citation Analysis]
79 Goswami A, Chandra S, Adhikari S, Mandal P. Understanding the Impact of the Microbiome on Lung Cancer. Microbiome in Inflammatory Lung Diseases 2022. [DOI: 10.1007/978-981-16-8957-4_10] [Reference Citation Analysis]
80 Talukdar A, Kataki AC, Banavali S, Ghosh J. Cancer: Infection and Vaccines. Fundamentals in Gynaecologic Malignancy 2022. [DOI: 10.1007/978-981-19-5860-1_4] [Reference Citation Analysis]
81 Chauhan NS. Microbiome, Therapeutics Application and Epigenetics: Conclusion and Future Prospective. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00025-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
82 Samanta S. Prospective role of prebiotics and probiotics in gut immunity. Microbiome, Immunity, Digestive Health and Nutrition 2022. [DOI: 10.1016/b978-0-12-822238-6.00014-5] [Reference Citation Analysis]
83 Rais A, Chand P, Malik M, Prasad T. Human microbiota: role in cancer progression and therapy. Microbial Crosstalk with Immune System 2022. [DOI: 10.1016/b978-0-323-96128-8.00006-7] [Reference Citation Analysis]
84 Anisman H, Kusnecov AW. Microbiota and health. Cancer 2022. [DOI: 10.1016/b978-0-323-91904-3.00003-3] [Reference Citation Analysis]
85 Oniyangi AG, Nazir A. Microbiome: A Novel Therapeutics in Cancer Management. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00004-8] [Reference Citation Analysis]
86 Russo E, Boem F, Curini L, Amedei A. Gastrointestinal Cancers: What Is the Real Board of Microenvironment and the Role of Microbiota–Immunity Axis? Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_6] [Reference Citation Analysis]
87 Furusawa C, Tanabe K, Ishii C, Kagata N, Tomita M, Fukuda S. Decoding gut microbiota by imaging analysis of fecal samples. iScience 2021;24:103481. [PMID: 34927025 DOI: 10.1016/j.isci.2021.103481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Sędzikowska A, Szablewski L. Human Gut Microbiota in Health and Selected Cancers. Int J Mol Sci 2021;22:13440. [PMID: 34948234 DOI: 10.3390/ijms222413440] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
89 Lu S, Hu J, Xie X, Zhou R, Li F, Huang R, He J. Secondary Metabolites with Cytotoxic Activities from Streptomyces sp. BM-8 Isolated from the Feces of Equusquagga. Molecules 2021;26:7556. [PMID: 34946638 DOI: 10.3390/molecules26247556] [Reference Citation Analysis]
90 Li L, Wang Y, Mou Y, Wu H, Qin Y. KDM1A Identified as a Potential Oncogenic Driver and Prognostic Biomarker via Multi-Omics Analysis. Canadian Journal of Infectious Diseases and Medical Microbiology 2021;2021:1-18. [DOI: 10.1155/2021/4668565] [Reference Citation Analysis]
91 Deleemans JM, Gajtani Z, Baydoun M, Reimer RA, Piedalue KA, Carlson LE. The Use of Prebiotic and Probiotic Interventions for Treating Gastrointestinal and Psychosocial Health Symptoms in Cancer Patients and Survivors: A Systematic Review. Integr Cancer Ther 2021;20:15347354211061733. [PMID: 34844479 DOI: 10.1177/15347354211061733] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
92 Wang T, Wang P, Ge W, Shi C, Xiao G, Wang X, Lü X. Protective effect of a multi-strain probiotics mixture on azoxymethane/dextran sulfate sodium-induced colon carcinogenesis. Food Bioscience 2021;44:101346. [DOI: 10.1016/j.fbio.2021.101346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
93 Das SP, Ahmed SM, Naik B, Laha S, Bejai V. The human fungal pathogen Malassezia and its role in cancer. Fungal Biology Reviews 2021;38:9-24. [DOI: 10.1016/j.fbr.2021.08.002] [Reference Citation Analysis]
94 Heymann CJF, Bard JM, Heymann MF, Heymann D, Bobin-Dubigeon C. The intratumoral microbiome: Characterization methods and functional impact. Cancer Lett 2021;522:63-79. [PMID: 34517085 DOI: 10.1016/j.canlet.2021.09.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
95 Liu H, Yang J, Yan X, Li C, Elsabahy M, Chen L, Yang YW, Gao H. A dendritic polyamidoamine supramolecular system composed of pillar[5]arene and azobenzene for targeting drug-resistant colon cancer. J Mater Chem B 2021;9:9594-605. [PMID: 34783814 DOI: 10.1039/d1tb02134f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
96 Xuan DTM, Wu CC, Kao TJ, Ta HDK, Anuraga G, Andriani V, Athoillah M, Chiao CC, Wu YF, Lee KH, Wang CY, Chuang JY. Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients. Aging (Albany NY) 2021;13:24882-913. [PMID: 34839279 DOI: 10.18632/aging.203722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
97 Широбоков ВП, Янковський ДС, Димент ГС. Роль мікробіома в розвитку онкологічної патології. Вісник НАН України 2021. [DOI: 10.15407/visn2021.11.024] [Reference Citation Analysis]
98 Shahid RK, Ahmed S, Le D, Yadav S. Diabetes and Cancer: Risk, Challenges, Management and Outcomes. Cancers (Basel) 2021;13:5735. [PMID: 34830886 DOI: 10.3390/cancers13225735] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
99 Wang T, Wang P, Ge W, Shi C, Xiao G, Wang X, Lü X. The probiotic Companilactobacillus crustorum MN047 alleviates colitis-associated tumorigenesis via modulating the intestinal microenvironment. Food Funct 2021;12:11331-42. [PMID: 34668003 DOI: 10.1039/d1fo01531a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
100 Zhou H, Yuan Y, Wang H, Xiang W, Li S, Zheng H, Wen Y, Ming Y, Chen L, Zhou J. Gut Microbiota: A Potential Target for Cancer Interventions. Cancer Manag Res 2021;13:8281-96. [PMID: 34764691 DOI: 10.2147/CMAR.S328249] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
101 Huang X, Li M, Hou S, Tian B. Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review). Int J Oncol 2021;59:101. [PMID: 34738624 DOI: 10.3892/ijo.2021.5281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Zhao S, Zhu L, Feng W, Zhang L, Chen DD, Hu YC, Shen H. MicroRNA-602 prevents the development of inflammatory bowel diseases in a microbiota-dependent manner. Exp Ther Med 2021;22:1373. [PMID: 34659519 DOI: 10.3892/etm.2021.10808] [Reference Citation Analysis]
103 Youssef M, Ahmed HY, Zongo A, Korin A, Zhan F, Hady E, Umair M, Shahid Riaz Rajoka M, Xiong Y, Li B. Probiotic Supplements: Their Strategies in the Therapeutic and Prophylactic of Human Life-Threatening Diseases. Int J Mol Sci 2021;22:11290. [PMID: 34681948 DOI: 10.3390/ijms222011290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
104 Hull R, Lolas G, Makrogkikas S, Jensen LD, Syrigos KN, Evangelou G, Padayachy L, Egbor C, Mehrotra R, Makhafola TJ, Oyomno M, Dlamini Z. Microbiomics in Collusion with the Nervous System in Carcinogenesis: Diagnosis, Pathogenesis and Treatment. Microorganisms 2021;9:2129. [PMID: 34683450 DOI: 10.3390/microorganisms9102129] [Reference Citation Analysis]
105 Fasse S, Alarinta J, Frahm B, Wirtanen G. Bovine Colostrum for Human Consumption—Improving Microbial Quality and Maintaining Bioactive Characteristics through Processing. Dairy 2021;2:556-75. [DOI: 10.3390/dairy2040044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
106 Hou X, Zhang P, Du H, Chu W, Sun R, Qin S, Tian Y, Zhang Z, Xu F. Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer. Front Pharmacol 2021;12:725583. [PMID: 34603035 DOI: 10.3389/fphar.2021.725583] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
107 Tran KA, Kondrashova O, Bradley A, Williams ED, Pearson JV, Waddell N. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med 2021;13:152. [PMID: 34579788 DOI: 10.1186/s13073-021-00968-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 19.5] [Reference Citation Analysis]
108 Oh B, Boyle F, Pavlakis N, Clarke S, Eade T, Hruby G, Lamoury G, Carroll S, Morgia M, Kneebone A, Stevens M, Liu W, Corless B, Molloy M, Kong B, Libermann T, Rosenthal D, Back M. The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy? Cancers (Basel) 2021;13:4824. [PMID: 34638308 DOI: 10.3390/cancers13194824] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
109 Dalal P, Sharma D. Microbe defines the efficacy of chemotherapeutic drug: a complete paradigm. FEMS Microbiol Lett 2021;368:fnab116. [PMID: 34448860 DOI: 10.1093/femsle/fnab116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Rao Malla R, Marni R, Kumari S, Chakraborty A, Lalitha P. Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer. Clin Breast Cancer 2021:S1526-8209(21)00260-3. [PMID: 34625387 DOI: 10.1016/j.clbc.2021.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
111 Bobulescu IA, Pop LM, Mani C, Turner K, Rivera C, Khatoon S, Kairamkonda S, Hannan R, Palle K. Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma. Metabolites 2021;11:608. [PMID: 34564424 DOI: 10.3390/metabo11090608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
112 Huang PY, Yang YC, Wang CI, Hsiao PW, Chiang HI, Chen TW. Increase in Akkermansiaceae in Gut Microbiota of Prostate Cancer-Bearing Mice. Int J Mol Sci 2021;22:9626. [PMID: 34502535 DOI: 10.3390/ijms22179626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
113 Bouranis JA, Beaver LM, Choi J, Wong CP, Jiang D, Sharpton TJ, Stevens JF, Ho E. Composition of the Gut Microbiome Influences Production of Sulforaphane-Nitrile and Iberin-Nitrile from Glucosinolates in Broccoli Sprouts. Nutrients 2021;13:3013. [PMID: 34578891 DOI: 10.3390/nu13093013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
114 Beltran JF, Viafara-garcia S, Labrador AP, Basterrechea J. The Role of Periodontopathogens and Oral Microbiome in the Progression of Oral Cancer. A Review. TODENTJ 2021;15:367-76. [DOI: 10.2174/1874210602115010367] [Reference Citation Analysis]
115 Pham CH, Lee JE, Yu J, Lee SH, Yu KR, Hong J, Cho N, Kim S, Kang D, Lee S, Yoo HM. Anticancer Effects of Propionic Acid Inducing Cell Death in Cervical Cancer Cells. Molecules 2021;26:4951. [PMID: 34443546 DOI: 10.3390/molecules26164951] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
116 Vivarelli S, Falzone L, Leonardi GC, Salmeri M, Libra M. Novel insights on gut microbiota manipulation and immune checkpoint inhibition in cancer (Review). Int J Oncol 2021;59:75. [PMID: 34396439 DOI: 10.3892/ijo.2021.5255] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
117 Lee MH. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun (Lond) 2021. [PMID: 34355542 DOI: 10.1002/cac2.12200] [Reference Citation Analysis]
118 Jaye K, Li CG, Bhuyan DJ. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses. Crit Rev Oncol Hematol 2021;165:103429. [PMID: 34293459 DOI: 10.1016/j.critrevonc.2021.103429] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
119 Arun KB, Madhavan A, Sindhu R, Emmanual S, Binod P, Pugazhendhi A, Sirohi R, Reshmy R, Awasthi MK, Gnansounou E, Pandey A. Probiotics and gut microbiome - Prospects and challenges in remediating heavy metal toxicity. J Hazard Mater 2021;420:126676. [PMID: 34329091 DOI: 10.1016/j.jhazmat.2021.126676] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
120 Herreros-Pomares A, Llorens C, Soriano B, Zhang F, Gallach S, Bagan L, Murillo J, Jantus-Lewintre E, Bagan J. Oral microbiome in Proliferative Verrucous Leukoplakia exhibits loss of diversity and enrichment of pathogens. Oral Oncol 2021;120:105404. [PMID: 34225130 DOI: 10.1016/j.oraloncology.2021.105404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Sun Q, He M, Zhang M, Zeng S, Chen L, Zhao H, Yang H, Liu M, Ren S, Xu H. Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery. Front Pharmacol 2021;12:685002. [PMID: 34276374 DOI: 10.3389/fphar.2021.685002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
122 Bibbò S, Ianiro G, Giambò F, Settanni CR, Cammarota G, Gasbarrini A. Role of gut microbiome on immunotherapy efficacy in melanoma. Hum Vaccin Immunother 2021;:1-6. [PMID: 34190675 DOI: 10.1080/21645515.2021.1926759] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
123 Cesa-Luna C, Alatorre-Cruz JM, Carreño-López R, Quintero-Hernández V, Baez A. Emerging Applications of Bacteriocins as Antimicrobials, Anticancer Drugs, and Modulators of The Gastrointestinal Microbiota. Pol J Microbiol 2021;70:143-59. [PMID: 34349808 DOI: 10.33073/pjm-2021-020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
124 Chen L, Zhou X, Wang Y, Wang D, Ke Y, Zeng X. Propionate and Butyrate Produced by Gut Microbiota after Probiotic Supplementation Attenuate Lung Metastasis of Melanoma Cells in Mice. Mol Nutr Food Res 2021;65:e2100096. [PMID: 34061433 DOI: 10.1002/mnfr.202100096] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
125 Ouyang Y, Qiu Y, Liu Y, Zhu R, Chen Y, El-Seedi HR, Chen X, Zhao C. Cancer-fighting potentials of algal polysaccharides as nutraceuticals. Food Res Int 2021;147:110522. [PMID: 34399500 DOI: 10.1016/j.foodres.2021.110522] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
126 Dikeocha IJ, Al-kabsi AM, Hussin S, Alshawsh MA. Probiotic Administration Ameliorate Azoxymethane Induced-Carcinogenesis by Reducing the Formation of Aberrant Crypt Foci and Modulation Oxidative Stress in Rats. The 1st International Electronic Conference on Biomedicine 2021. [DOI: 10.3390/ecb2021-10255] [Reference Citation Analysis]
127 Jiang Z, Li L, Chen J, Wei G, Ji Y, Chen X, Liu J, Huo J. Human gut-microbiome interplay: Analysis of clinical studies for the emerging roles of diagnostic microbiology in inflammation, oncogenesis and cancer management. Infect Genet Evol 2021;93:104946. [PMID: 34052417 DOI: 10.1016/j.meegid.2021.104946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
128 Giambò F, Teodoro M, Costa C, Fenga C. Toxicology and Microbiota: How Do Pesticides Influence Gut Microbiota? A Review. Int J Environ Res Public Health 2021;18:5510. [PMID: 34063879 DOI: 10.3390/ijerph18115510] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
129 Bonde A, Daly S, Kirsten J, Kondapaneni S, Mellnick V, Menias CO, Katabathina VS. Human Gut Microbiota-associated Gastrointestinal Malignancies: A Comprehensive Review. Radiographics 2021;41:1103-22. [PMID: 33989072 DOI: 10.1148/rg.2021200168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
130 Borella F, Carosso AR, Cosma S, Preti M, Collemi G, Cassoni P, Bertero L, Benedetto C. Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions. ACS Infect Dis 2021;7:987-1009. [PMID: 33848139 DOI: 10.1021/acsinfecdis.0c00839] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
131 Kalia VC, Patel SKS, Cho BK, Wood TK, Lee JK. Emerging applications of bacteria as antitumor agents. Semin Cancer Biol 2021:S1044-579X(21)00140-1. [PMID: 33989734 DOI: 10.1016/j.semcancer.2021.05.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
132 Wang Q, Liu Z, Yan B, Chou WC, Ettwiller L, Ma Q, Liu B. A novel computational framework for genome-scale alternative transcription units prediction. Brief Bioinform 2021:bbab162. [PMID: 33957668 DOI: 10.1093/bib/bbab162] [Reference Citation Analysis]
133 Sobolewska A, Dunisławska A, Stadnicka K. Natural substances in cancer—do they work? Physical Sciences Reviews 2021;0. [DOI: 10.1515/psr-2019-0060] [Reference Citation Analysis]
134 Anelli L, Di Nardo A, Bonucci M. Integrative Treatment of Lung Cancer Patients: Observational Study of 57 Cases. Asian Journal of Oncology 2021;07:064-75. [DOI: 10.1055/s-0040-1722380] [Reference Citation Analysis]
135 Kullar R, Johnson S, McFarland LV, Goldstein EJC. Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use. Antibiotics (Basel) 2021;10:408. [PMID: 33918619 DOI: 10.3390/antibiotics10040408] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
136 Carretta MD, Quiroga J, López R, Hidalgo MA, Burgos RA. Participation of Short-Chain Fatty Acids and Their Receptors in Gut Inflammation and Colon Cancer. Front Physiol 2021;12:662739. [PMID: 33897470 DOI: 10.3389/fphys.2021.662739] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
137 Ranjbar M, Salehi R, Haghjooy Javanmard S, Rafiee L, Faraji H, Jafarpor S, Ferns GA, Ghayour-Mobarhan M, Manian M, Nedaeinia R. The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review. Cancer Cell Int 2021;21:194. [PMID: 33823861 DOI: 10.1186/s12935-021-01886-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
138 Requena T, Velasco M. Microbioma humano en la salud y la enfermedad. Revista Clínica Española 2021;221:233-40. [DOI: 10.1016/j.rce.2019.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
139 Li P, Hao Z, Liu H, Zhu B, Dang L, Ma C, Xu Y, Zhang Y, Fan D, Sun S. Quantitative Proteomics Analysis of Berberine-Treated Colon Cancer Cells Reveals Potential Therapy Targets. Biology (Basel) 2021;10:250. [PMID: 33806918 DOI: 10.3390/biology10030250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
140 Gaucher L, Adda L, Séjourné A, Joachim C, Guillaume C, Poulet C, Liabeuf S, Gras-Champel V, Masmoudi K, Houessinon A, Bennis Y, Batteux B. Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors. Ther Adv Med Oncol 2021;13:17588359211000591. [PMID: 33796151 DOI: 10.1177/17588359211000591] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
141 Dieleman S, Aarnoutse R, Ziemons J, Kooreman L, Boleij A, Smidt M. Exploring the Potential of Breast Microbiota as Biomarker for Breast Cancer and Therapeutic Response. Am J Pathol 2021;191:968-82. [PMID: 33713687 DOI: 10.1016/j.ajpath.2021.02.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
142 Li H, Li H. Introduction to Special Issue on Statistics in Microbiome and Metagenomics. Stat Biosci 2021;13:197-9. [DOI: 10.1007/s12561-021-09307-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 Dayi T, Öniz A. RE-VISITED; ARE FOODS FRIEND OR FOE FOR CANCER? Journal of Basic and Clinical Health Sciences. [DOI: 10.30621/jbachs.854439] [Reference Citation Analysis]
144 Wang L, Peng F, Peng C, Du JR. Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine. Am J Chin Med 2021;49:609-26. [PMID: 33683187 DOI: 10.1142/S0192415X21500270] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
145 Trivedi R, Barve K. Gut microbiome a promising target for management of respiratory diseases. Biochem J 2020;477:2679-96. [PMID: 32726437 DOI: 10.1042/BCJ20200426] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
146 Shardell M, Parimi N, Langsetmo L, Tanaka T, Jiang L, Orwoll E, Shikany JM, Kado DM, Cawthon PM. Comparing Analytical Methods for the Gut Microbiome and Aging: Gut Microbial Communities and Body Weight in the Osteoporotic Fractures in Men (MrOS) Study. J Gerontol A Biol Sci Med Sci 2020;75:1267-75. [PMID: 32025711 DOI: 10.1093/gerona/glaa034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
147 Hardy BL, Merrell DS. Friend or Foe: Interbacterial Competition in the Nasal Cavity. J Bacteriol 2021;203:e00480-20. [PMID: 33077632 DOI: 10.1128/JB.00480-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
148 Kumari S, Bhor VM. Association of cervicovaginal dysbiosis mediated HPV infection with cervical intraepithelial neoplasia. Microb Pathog 2021;152:104780. [PMID: 33545325 DOI: 10.1016/j.micpath.2021.104780] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
149 Bonmati-Carrion MA, Tomas-Loba A. Melatonin and Cancer: A Polyhedral Network Where the Source Matters. Antioxidants (Basel) 2021;10:210. [PMID: 33535472 DOI: 10.3390/antiox10020210] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
150 Kadam S, Vandana M, Patwardhan S, Kaushik KS. Looking beyond the smokescreen: can the oral microbiome be a tool or target in the management of tobacco-associated oral cancer? Ecancermedicalscience 2021;15:1179. [PMID: 33777172 DOI: 10.3332/ecancer.2021.1179] [Reference Citation Analysis]
151 Caspi M, Wittenstein A, Kazelnik M, Shor-Nareznoy Y, Rosin-Arbesfeld R. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Adv Drug Deliv Rev 2021;169:118-36. [PMID: 33346022 DOI: 10.1016/j.addr.2020.12.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 18.0] [Reference Citation Analysis]
152 Hu-Lieskovan S, Malouf GG, Jacobs I, Chou J, Liu L, Johnson ML. Addressing resistance to immune checkpoint inhibitor therapy: an urgent unmet need. Future Oncol 2021;17:1401-39. [PMID: 33475012 DOI: 10.2217/fon-2020-0967] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
153 Wang Q, Liu Z, Yan B, Chou W, Ettwiller L, Ma Q, Liu B. Analysis of next- and third-generation RNA-Seq data reveals the structures of alternative transcription units in bacterial genomes.. [DOI: 10.1101/2021.01.02.425006] [Reference Citation Analysis]
154 Emmanuel Nweke E, Suleman E, Du Plessis M, Thimiri Govinda Raj DB. Bioinformatics Tools for Gene and Genome Annotation Analysis of Microbes for Synthetic Biology and Cancer Biology Applications. Advances in Bioinformatics 2021. [DOI: 10.1007/978-981-33-6191-1_16] [Reference Citation Analysis]
155 Mulenga M, Kareem SA, Sabri AQM, Seera M. Stacking and Chaining of Normalization Methods in Deep Learning-Based Classification of Colorectal Cancer Using Gut Microbiome Data. IEEE Access 2021;9:97296-97319. [DOI: 10.1109/access.2021.3094529] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
156 Malaviya A, Paari KA, Malviya S, Kondapalli VK, Ghosh A, Samuel RA. Gut Microbiota and Cancer Correlates. Probiotic Research in Therapeutics 2021. [DOI: 10.1007/978-981-15-8214-1_1] [Reference Citation Analysis]
157 Theodoropoulos GE. Gut Microbiome and Cancer. Gut Microbiome-Related Diseases and Therapies 2021. [DOI: 10.1007/978-3-030-59642-2_4] [Reference Citation Analysis]
158 Martín Ortega A, Segura Campos M. Macronutrients and micronutrients in cancer prevention and treatment. Oncological Functional Nutrition 2021. [DOI: 10.1016/b978-0-12-819828-5.00003-6] [Reference Citation Analysis]
159 Dasgupta N, Srivastava A, Rao A, Murugkar V, Shroff R, Das G. Microbiome Diagnostics and Interventions in Health and Disease. Microbiome in Human Health and Disease 2021. [DOI: 10.1007/978-981-16-3156-6_10] [Reference Citation Analysis]
160 Tran L, Forsyth CB, Bishehsari F, Voigt RM, Keshavarzian A, Swanson GR. Disease Implications of the Circadian Clocks and Microbiota Interface. Circadian Rhythms in Bacteria and Microbiomes 2021. [DOI: 10.1007/978-3-030-72158-9_17] [Reference Citation Analysis]
161 Fajardo-orduña G, Chamorro-plata D. Molecular and therapeutic bases of cancer. Oncological Functional Nutrition 2021. [DOI: 10.1016/b978-0-12-819828-5.00002-4] [Reference Citation Analysis]
162 Carlson LE, Toivonen K, Flynn M, Deleemans J, Piedalue K, Subnis U, Oberoi D, Patton M, Pirbhai H, Baydoun M. Mindfulness-Based Stress Reduction for Medical Conditions. Biopsychosocial Factors of Stress, and Mindfulness for Stress Reduction 2021. [DOI: 10.1007/978-3-030-81245-4_7] [Reference Citation Analysis]
163 Zhang X, Daniel CR. Diet, Microbiome, Inflammation, and Cancer. Physiology in Health and Disease 2021. [DOI: 10.1007/978-3-030-67951-4_11] [Reference Citation Analysis]
164 Loo YS, Bose RJ, McCarthy JR, Mat Azmi ID, Madheswaran T. Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications. Drug Discov Today 2021;26:902-15. [PMID: 33383213 DOI: 10.1016/j.drudis.2020.12.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
165 Burri S, Granheimer K, Rémy M, Tannira V, So Y, Rumpunen K, Tornberg E, Canaviri Paz P, Uhlig E, Oscarsson E, Rohrstock AM, Rahman M, Håkansson Å. Processed meat products with added plant antioxidants affect the microbiota and immune response in C57BL/6JRj mice with cyclically induced chronic inflammation. Biomed Pharmacother 2021;135:111133. [PMID: 33383374 DOI: 10.1016/j.biopha.2020.111133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
166 Zhang Y, Zhao N, Yang L, Hong Z, Cai B, Le Q, Yang T, Shi L, He J, Cui CB. Insoluble dietary fiber derived from brown seaweed Laminaria japonica ameliorate obesity-related features via modulating gut microbiota dysbiosis in high-fat diet-fed mice. Food Funct 2021;12:587-601. [PMID: 33350422 DOI: 10.1039/d0fo02380a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
167 Ravegnini G, Fosso B, Saverio VD, Sammarini G, Zanotti F, Rossi G, Ricci M, D'Amico F, Valori G, Ioli A, Turroni S, Brigidi P, Hrelia P, Angelini S. Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis-Deepening Heterogeneity for a Personalized Therapy. Int J Mol Sci 2020;21:E9735. [PMID: 33419357 DOI: 10.3390/ijms21249735] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
168 Badgeley A, Anwar H, Modi K, Murphy P, Lakshmikuttyamma A. Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives. Biochim Biophys Acta Rev Cancer 2021;1875:188494. [PMID: 33346129 DOI: 10.1016/j.bbcan.2020.188494] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
169 Dayi T, Hoca M. Glisemik İndeks, Glisemik Yük ve Kanser Arasındaki Potansiyel İlişki. Sağlık Bilimleri Dergisi 2020. [DOI: 10.34108/eujhs.669377] [Reference Citation Analysis]
170 Docimo G, Cangiano A, Romano RM, Pignatelli MF, Offi C, Paglionico VA, Galdiero M, Donnarumma G, Nigro V, Esposito D, Rotondi M, Candela G, Pasquali D. The Human Microbiota in Endocrinology: Implications for Pathophysiology, Treatment, and Prognosis in Thyroid Diseases. Front Endocrinol (Lausanne) 2020;11:586529. [PMID: 33343507 DOI: 10.3389/fendo.2020.586529] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
171 Sampsell K, Hao D, Reimer RA. The Gut Microbiota: A Potential Gateway to Improved Health Outcomes in Breast Cancer Treatment and Survivorship. Int J Mol Sci 2020;21:E9239. [PMID: 33287442 DOI: 10.3390/ijms21239239] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
172 García-Peñarrubia P, Ruiz-Alcaraz AJ, Martínez-Esparza M, Marín P, Machado-Linde F. Hypothetical roadmap towards endometriosis: prenatal endocrine-disrupting chemical pollutant exposure, anogenital distance, gut-genital microbiota and subclinical infections. Hum Reprod Update 2020;26:214-46. [PMID: 32108227 DOI: 10.1093/humupd/dmz044] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
173 Shang F, Jiang X, Wang H, Chen S, Wang X, Liu Y, Guo S, Li D, Yu W, Zhao Z, Wang G. The inhibitory effects of probiotics on colon cancer cells: in vitro and in vivo studies. J Gastrointest Oncol 2020;11:1224-32. [PMID: 33456995 DOI: 10.21037/jgo-20-573] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
174 Baghbani T, Nikzad H, Azadbakht J, Izadpanah F, Haddad Kashani H. Dual and mutual interaction between microbiota and viral infections: a possible treat for COVID-19. Microb Cell Fact. 2020;19:217. [PMID: 33243230 DOI: 10.1186/s12934-020-01483-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
175 Diamante G, Cely I, Zamora Z, Ding J, Blencowe M, Lang J, Bline A, Singh M, Lusis AJ, Yang X. Systems toxicogenomics of prenatal low-dose BPA exposure on liver metabolic pathways, gut microbiota, and metabolic health in mice. Environ Int 2021;146:106260. [PMID: 33221593 DOI: 10.1016/j.envint.2020.106260] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
176 Greco C, Catania R, Balacco DL, Taresco V, Musumeci F, Alexander C, Huett A, Schenone S. Synthesis and Antibacterial Evaluation of New Pyrazolo[3,4-d]pyrimidines Kinase Inhibitors. Molecules 2020;25:E5354. [PMID: 33207806 DOI: 10.3390/molecules25225354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
177 Michels N, van Aart C, Morisse J, Mullee A, Huybrechts I. Chronic inflammation towards cancer incidence: A systematic review and meta-analysis of epidemiological studies. Crit Rev Oncol Hematol 2021;157:103177. [PMID: 33264718 DOI: 10.1016/j.critrevonc.2020.103177] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
178 Jeitler M, Michalsen A, Frings D, Hübner M, Fischer M, Koppold-Liebscher DA, Murthy V, Kessler CS. Significance of Medicinal Mushrooms in Integrative Oncology: A Narrative Review. Front Pharmacol 2020;11:580656. [PMID: 33424591 DOI: 10.3389/fphar.2020.580656] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
179 Chen L, Li Z, Zeng T, Zhang YH, Liu D, Li H, Huang T, Cai YD. Identifying Robust Microbiota Signatures and Interpretable Rules to Distinguish Cancer Subtypes. Front Mol Biosci 2020;7:604794. [PMID: 33330634 DOI: 10.3389/fmolb.2020.604794] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
180 Kamareddine L, Najjar H, Sohail MU, Abdulkader H, Al-Asmakh M. The Microbiota and Gut-Related Disorders: Insights from Animal Models. Cells 2020;9:E2401. [PMID: 33147801 DOI: 10.3390/cells9112401] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
181 Caenepeel C, Sadat Seyed Tabib N, Vieira-Silva S, Vermeire S. Review article: how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease. Aliment Pharmacol Ther 2020;52:1453-68. [PMID: 32969507 DOI: 10.1111/apt.16096] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
182 Sami A, Elimairi I, Stanton C, Ross RP, Ryan CA. The Role of the Microbiome in Oral Squamous Cell Carcinoma with Insight into the Microbiome-Treatment Axis. Int J Mol Sci 2020;21:E8061. [PMID: 33137960 DOI: 10.3390/ijms21218061] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
183 Mravec B, Horvathova L, Hunakova L. Neurobiology of Cancer: the Role of β-Adrenergic Receptor Signaling in Various Tumor Environments. Int J Mol Sci 2020;21:E7958. [PMID: 33114769 DOI: 10.3390/ijms21217958] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
184 Miarons M, Roca M, Salvà F. The role of pro-, pre- and symbiotics in cancer: A systematic review. J Clin Pharm Ther 2021;46:50-65. [PMID: 33095928 DOI: 10.1111/jcpt.13292] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
185 Teng J, Zhao Y, Jiang Y, Wang Q, Zhang Y. [Correlation between Gut Microbiota and Lung Cancer]. Zhongguo Fei Ai Za Zhi 2020;23:909-15. [PMID: 32798442 DOI: 10.3779/j.issn.1009-3419.2020.101.39] [Reference Citation Analysis]
186 Zhang C, Yang M, Ericsson AC. The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer. Front Oncol 2020;10:524205. [PMID: 33163393 DOI: 10.3389/fonc.2020.524205] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
187 Wang J, Yang HR, Wang DJ, Wang XX. Association between the gut microbiota and patient responses to cancer immune checkpoint inhibitors. Oncol Lett 2020;20:342. [PMID: 33123253 DOI: 10.3892/ol.2020.12205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
188 Wang L, Wang R, Wei GY, Zhang RP, Zhu Y, Wang Z, Wang SM, Du GH. Cryptotanshinone alleviates chemotherapy-induced colitis in mice with colon cancer via regulating fecal-bacteria-related lipid metabolism. Pharmacol Res 2021;163:105232. [PMID: 33027716 DOI: 10.1016/j.phrs.2020.105232] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
189 Cammarota G, Ianiro G, Ahern A, Carbone C, Temko A, Claesson MJ, Gasbarrini A, Tortora G. Gut microbiome, big data and machine learning to promote precision medicine for cancer. Nat Rev Gastroenterol Hepatol 2020;17:635-48. [PMID: 32647386 DOI: 10.1038/s41575-020-0327-3] [Cited by in Crossref: 93] [Cited by in F6Publishing: 90] [Article Influence: 31.0] [Reference Citation Analysis]
190 Hopson LM, Singleton SS, David JA, Basuchoudhary A, Prast-Nielsen S, Klein P, Sen S, Mazumder R. Bioinformatics and machine learning in gastrointestinal microbiome research and clinical application. Prog Mol Biol Transl Sci 2020;176:141-78. [PMID: 33814114 DOI: 10.1016/bs.pmbts.2020.08.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
191 Mola S, Pandolfo C, Sica A, Porta C. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance. Int J Mol Sci 2020;21:E6866. [PMID: 32962159 DOI: 10.3390/ijms21186866] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
192 Rivera Espinoza Y. Microbiota intestinal: su importancia en la salud y los factores que la modifican. LAJCSMT 2020;2:185-196. [DOI: 10.34141/ljcs3995284] [Reference Citation Analysis]
193 Leggio L, Paternò G, Vivarelli S, L'Episcopo F, Tirolo C, Raciti G, Pappalardo F, Giachino C, Caniglia S, Serapide MF, Marchetti B, Iraci N. Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease. Biomolecules 2020;10:E1327. [PMID: 32948090 DOI: 10.3390/biom10091327] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
194 Vitale G, Dicitore A, Barrea L, Sbardella E, Razzore P, Campione S, Faggiano A, Colao A, Albertelli M, Altieri B, Bottiglieri F, De Cicco F, Di Molfetta S, Fanciulli G, Feola T, Ferone D, Ferraù F, Gallo M, Giannetta E, Grillo F, Grossrubatscher E, Guadagno E, Guarnotta V, Isidori AM, Lania A, Lenzi A, Calzo FL, Malandrino P, Messina E, Modica R, Muscogiuri G, Pes L, Pizza G, Pofi R, Puliani G, Rainone C, Rizza L, Rubino M, Ruggieri RM, Sesti F, Venneri MA, Zatelli MC; NIKE. From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? Rev Endocr Metab Disord 2021;22:511-25. [PMID: 32935263 DOI: 10.1007/s11154-020-09589-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
195 Gunathilake M, Lee J, Choi IJ, Kim YI, Yoon J, Sul WJ, Kim JF, Kim J. Alterations in Gastric Microbial Communities Are Associated with Risk of Gastric Cancer in a Korean Population: A Case-Control Study.Cancers (Basel). 2020;12. [PMID: 32937864 DOI: 10.3390/cancers12092619] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
196 Aponte M, Murru N, Shoukat M. Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective. Front Microbiol 2020;11:562048. [PMID: 33042069 DOI: 10.3389/fmicb.2020.562048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
197 Falzone L, Grimaldi M, Celentano E, Augustin LSA, Libra M. Identification of Modulated MicroRNAs Associated with Breast Cancer, Diet, and Physical Activity. Cancers (Basel) 2020;12:E2555. [PMID: 32911851 DOI: 10.3390/cancers12092555] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 11.7] [Reference Citation Analysis]
198 Amadei SS, Notario V. A Significant Question in Cancer Risk and Therapy: Are Antibiotics Positive or Negative Effectors? Current Answers and Possible Alternatives. Antibiotics (Basel) 2020;9:E580. [PMID: 32899961 DOI: 10.3390/antibiotics9090580] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
199 Lolli C, Altavilla A, Conteduca V, Farolfi A, Casadei C, Schepisi G, Banna GL, De Giorgi U. A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma. Critical Reviews in Oncology/Hematology 2020;153:103036. [DOI: 10.1016/j.critrevonc.2020.103036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
200 Katongole P, Sande OJ, Joloba M, Reynolds SJ, Niyonzima N. The human microbiome and its link in prostate cancer risk and pathogenesis. Infect Agent Cancer 2020;15:53. [PMID: 32884579 DOI: 10.1186/s13027-020-00319-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
201 Fiorentini C, Carlini F, Germinario EAP, Maroccia Z, Travaglione S, Fabbri A. Gut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins? Int J Mol Sci 2020;21:E6201. [PMID: 32867331 DOI: 10.3390/ijms21176201] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
202 Zhu H, He YS, Ma J, Zhou J, Kong M, Wu CY, Mao Q, Lin G, Li SL. The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice. J Ethnopharmacol 2021;265:113271. [PMID: 32853742 DOI: 10.1016/j.jep.2020.113271] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
203 Phipps O, Al-Hassi HO, Quraishi MN, Kumar A, Brookes MJ. Influence of Iron on the Gut Microbiota in Colorectal Cancer. Nutrients 2020;12:E2512. [PMID: 32825236 DOI: 10.3390/nu12092512] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
204 Hsiao YC, Liu CW, Chi L, Yang Y, Lu K. Effects of Gut Microbiome on Carcinogenic DNA Damage. Chem Res Toxicol 2020;33:2130-8. [PMID: 32677427 DOI: 10.1021/acs.chemrestox.0c00142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
205 Chattopadhyay I, Nandi D, Nag A. The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy. Semin Cancer Biol 2021;70:98-111. [PMID: 32739479 DOI: 10.1016/j.semcancer.2020.07.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
206 Vaiserman A, Romanenko M, Piven L, Moseiko V, Lushchak O, Kryzhanovska N, Guryanov V, Koliada A. Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol 2020;20:221. [PMID: 32698765 DOI: 10.1186/s12866-020-01903-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 15.0] [Reference Citation Analysis]
207 Lim HH, Hopkins AM, Rowland A, Yuen HY, Karapetis CS, Sorich MJ. Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab. Target Oncol 2019;14:743-8. [PMID: 31676953 DOI: 10.1007/s11523-019-00683-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
208 Fidelis M, Santos JS, Escher GB, Rocha RS, Cruz AG, Cruz TM, Marques MB, Nunes JB, do Carmo MAV, de Almeida LA, Kaneshima T, Azevedo L, Granato D. Polyphenols of jabuticaba [Myrciaria jaboticaba (Vell.) O.Berg] seeds incorporated in a yogurt model exert antioxidant activity and modulate gut microbiota of 1,2-dimethylhydrazine-induced colon cancer in rats. Food Chem 2021;334:127565. [PMID: 32717686 DOI: 10.1016/j.foodchem.2020.127565] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 9.3] [Reference Citation Analysis]
209 Zouggar A, Haebe JR, Benoit YD. Intestinal Microbiota Influences DNA Methylome and Susceptibility to Colorectal Cancer. Genes (Basel) 2020;11:E808. [PMID: 32708659 DOI: 10.3390/genes11070808] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
210 Brocco D, Florio R, De Lellis L, Veschi S, Grassadonia A, Tinari N, Cama A. The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective. Cancers (Basel) 2020;12:E1849. [PMID: 32659999 DOI: 10.3390/cancers12071849] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
211 Sulaiman I, Schuster S, Segal LN. Perspectives in lung microbiome research. Curr Opin Microbiol 2020;56:24-9. [PMID: 32623064 DOI: 10.1016/j.mib.2020.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
212 Aindelis G, Chlichlia K. Modulation of Anti-Tumour Immune Responses by Probiotic Bacteria. Vaccines (Basel) 2020;8:E329. [PMID: 32575876 DOI: 10.3390/vaccines8020329] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
213 Chakladar J, Wong LM, Kuo SZ, Li WT, Yu MA, Chang EY, Wang XQ, Ongkeko WM. The Liver Microbiome Is Implicated in Cancer Prognosis and Modulated by Alcohol and Hepatitis B. Cancers (Basel) 2020;12:E1642. [PMID: 32575865 DOI: 10.3390/cancers12061642] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
214 Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. Front Immunol 2020;11:906. [PMID: 32582143 DOI: 10.3389/fimmu.2020.00906] [Cited by in Crossref: 281] [Cited by in F6Publishing: 310] [Article Influence: 93.7] [Reference Citation Analysis]
215 Marsova M, Odorskaya M, Novichkova M, Polyakova V, Abilev S, Kalinina E, Shtil A, Poluektova E, Danilenko V. The Lactobacillus brevis 47 f Strain Protects the Murine Intestine from Enteropathy Induced by 5-Fluorouracil. Microorganisms 2020;8:E876. [PMID: 32527057 DOI: 10.3390/microorganisms8060876] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
216 Lara R, Adinolfi E, Harwood CA, Philpott M, Barden JA, Di Virgilio F, McNulty S. P2X7 in Cancer: From Molecular Mechanisms to Therapeutics. Front Pharmacol 2020;11:793. [PMID: 32581786 DOI: 10.3389/fphar.2020.00793] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 17.3] [Reference Citation Analysis]
217 Joseph NT, Shankar SR, Narasimhamurthy RK, Rao SBS, Mumbrekar KD. Bi-Directional interactions between microbiota and ionizing radiation in head and neck and pelvic radiotherapy - clinical relevance. Int J Radiat Biol 2020;96:961-71. [PMID: 32420768 DOI: 10.1080/09553002.2020.1770361] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
218 White JR, Dauros-singorenko P, Hong J, Vanholsbeeck F, Phillips A, Swift S. The role of host molecules in communication with the resident and pathogenic microbiota: A review. Medicine in Microecology 2020;4:100005. [DOI: 10.1016/j.medmic.2020.100005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
219 Loo YT, Howell K, Chan M, Zhang P, Ng K. Modulation of the human gut microbiota by phenolics and phenolic fiber-rich foods. Compr Rev Food Sci Food Saf 2020;19:1268-98. [PMID: 33337077 DOI: 10.1111/1541-4337.12563] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 21.3] [Reference Citation Analysis]
220 Kaźmierczak-Siedlecka K, Dvořák A, Folwarski M, Daca A, Przewłócka K, Makarewicz W. Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis. Cancers (Basel) 2020;12:E1326. [PMID: 32455985 DOI: 10.3390/cancers12051326] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
221 Ashraf-Uz-Zaman M, Bhalerao A, Mikelis CM, Cucullo L, German NA. Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview. Cancers (Basel) 2020;12:E1265. [PMID: 32429547 DOI: 10.3390/cancers12051265] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
222 Fakhri S, Khodamorady M, Naseri M, Farzaei MH, Khan H. The ameliorating effects of anthocyanins on the cross-linked signaling pathways of cancer dysregulated metabolism. Pharmacol Res 2020;159:104895. [PMID: 32422342 DOI: 10.1016/j.phrs.2020.104895] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
223 Napoli S, Scuderi C, Gattuso G, Bella VD, Candido S, Basile MS, Libra M, Falzone L. Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma. Cells 2020;9:E1151. [PMID: 32392801 DOI: 10.3390/cells9051151] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 14.3] [Reference Citation Analysis]
224 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
225 Niu J, Zhou L, Liu Z, Pei D, Fan W, Ning W. A Systematic Review and Meta-Analysis of the Effects of Perioperative Immunonutrition in Gastrointestinal Cancer Patients. Nutrition and Cancer 2021;73:252-61. [DOI: 10.1080/01635581.2020.1749291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
226 Brown SA, Ray JC, Herrmann J. Precision Cardio-Oncology: a Systems-Based Perspective on Cardiotoxicity of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors. J Cardiovasc Transl Res 2020;13:402-16. [PMID: 32253744 DOI: 10.1007/s12265-020-09992-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
227 Nunes SC, Serpa J. Recycling the Interspecific Relations with Epithelial Cells: Bacteria and Cancer Metabolic Symbiosis. Adv Exp Med Biol 2020;1219:77-91. [PMID: 32130694 DOI: 10.1007/978-3-030-34025-4_4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
228 La Rosa GRM, Gattuso G, Pedullà E, Rapisarda E, Nicolosi D, Salmeri M. Association of oral dysbiosis with oral cancer development. Oncol Lett 2020;19:3045-58. [PMID: 32211076 DOI: 10.3892/ol.2020.11441] [Cited by in Crossref: 29] [Cited by in F6Publishing: 38] [Article Influence: 9.7] [Reference Citation Analysis]
229 Siokas V, Aslanidou P, Aloizou A, Peristeri E, Stamati P, Liampas I, Arseniou S, Drakoulis N, Aschner M, Tsatsakis A, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer’s Disease? J Mol Neurosci 2020;70:851-60. [DOI: 10.1007/s12031-020-01507-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
230 Walker SP, Tangney M, Claesson MJ. Sequence-Based Characterization of Intratumoral Bacteria-A Guide to Best Practice. Front Oncol 2020;10:179. [PMID: 32154174 DOI: 10.3389/fonc.2020.00179] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
231 Requena T, Velasco M. The human microbiome in sickness and in health. Rev Clin Esp (Barc) 2021;221:233-40. [PMID: 33998505 DOI: 10.1016/j.rceng.2019.07.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
232 Zhang L, Liu Y, Zheng HJ, Zhang CP. The Oral Microbiota May Have Influence on Oral Cancer. Front Cell Infect Microbiol 2019;9:476. [PMID: 32010645 DOI: 10.3389/fcimb.2019.00476] [Cited by in Crossref: 97] [Cited by in F6Publishing: 105] [Article Influence: 32.3] [Reference Citation Analysis]
233 Fernandes MF, de Oliveira S, Portovedo M, Rodrigues PB, Vinolo MAR. Effect of Short Chain Fatty Acids on Age-Related Disorders. Adv Exp Med Biol 2020;1260:85-105. [PMID: 32304031 DOI: 10.1007/978-3-030-42667-5_4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
234 Gheorghe S, Negru Ş, Preda M, Mihai MM, Manolescu LSC, Popa MI, Stănculeanu DL. Microbiome implications in carcinogenesis initiation and promotion. Oncolog-Hematolog ro 2020;2:17. [DOI: 10.26416/onhe.51.2.2020.3188] [Reference Citation Analysis]
235 Tabashsum Z, Alvarado-martinez Z, Houser A, Padilla J, Shah N, Young A. Contribution of Human and Animal to the Microbial World and Ecological Balance. Gut Microbiome and Its Impact on Health and Diseases 2020. [DOI: 10.1007/978-3-030-47384-6_1] [Reference Citation Analysis]
236 Francescangeli F, De Angelis ML, Zeuner A. Dietary Factors in the Control of Gut Homeostasis, Intestinal Stem Cells, and Colorectal Cancer. Nutrients 2019;11:E2936. [PMID: 31816977 DOI: 10.3390/nu11122936] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
237 Dave A, Wiseman JT, Cloyd JM. Duodenal adenocarcinoma: neoadjuvant and adjuvant therapy strategies. Expert Opinion on Orphan Drugs 2019;7:463-72. [DOI: 10.1080/21678707.2019.1684257] [Reference Citation Analysis]
238 Cheng GS, Bondeelle L, Gooley T, He Q, Jamani K, Krakow EF, Flowers MED, de Latour RP, Michonneau D, Socié G, Chien JW, Chevret S, Bergeron A. Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2020;26:392-400. [PMID: 31682980 DOI: 10.1016/j.bbmt.2019.10.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
239 Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, Kovatsi L, Spandidos DA, Drakoulis N, Kalogeraki A, Mamoulakis C, Tzanakakis G, Libra M, Tsatsakis A. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells 2019;8:E1251. [PMID: 31615102 DOI: 10.3390/cells8101251] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 10.0] [Reference Citation Analysis]
240 Christofi T, Baritaki S, Falzone L, Libra M, Zaravinos A. Current Perspectives in Cancer Immunotherapy. Cancers (Basel) 2019;11:E1472. [PMID: 31575023 DOI: 10.3390/cancers11101472] [Cited by in Crossref: 114] [Cited by in F6Publishing: 122] [Article Influence: 28.5] [Reference Citation Analysis]
241 Sha S, Ni L, Stefil M, Dixon M, Mouraviev V. The human gastrointestinal microbiota and prostate cancer development and treatment. Investig Clin Urol 2020;61:S43-50. [PMID: 32055753 DOI: 10.4111/icu.2020.61.S1.S43] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
242 Arias-Borrego A, Callejón-Leblic B, Calatayud M, Gómez-Ariza JL, Collado MC, García-Barrera T. Insights into cancer and neurodegenerative diseases through selenoproteins and the connection with gut microbiota - current analytical methodologies. Expert Rev Proteomics 2019;16:805-14. [PMID: 31482748 DOI: 10.1080/14789450.2019.1664292] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
243 Villéger R, Lopès A, Carrier G, Veziant J, Billard E, Barnich N, Gagnière J, Vazeille E, Bonnet M. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? Int J Mol Sci 2019;20:E4584. [PMID: 31533218 DOI: 10.3390/ijms20184584] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 12.3] [Reference Citation Analysis]
244 Wheeler KM, Liss MA. The Microbiome and Prostate Cancer Risk. Curr Urol Rep 2019;20. [DOI: 10.1007/s11934-019-0922-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
245 Arita S, Ogawa T, Murakami Y, Kinoshita Y, Okazaki M, Inagaki-Ohara K. Dietary Fat-Accelerating Leptin Signaling Promotes Protumorigenic Gastric Environment in Mice. Nutrients 2019;11:E2127. [PMID: 31489936 DOI: 10.3390/nu11092127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
246 Doukas S, Vageli D, Nikolouzakis T, Falzone L, Docea A, Lazopoulos G, Kalbakis K, Tsatsakis A. Role of DNA mismatch repair genes in lung and head and neck cancer (Review). Wrld Acd Sci 2019. [DOI: 10.3892/wasj.2019.21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
247 Brusselaers N. Prescribed Drugs and the Microbiome. Gastroenterol Clin North Am 2019;48:331-42. [PMID: 31383274 DOI: 10.1016/j.gtc.2019.04.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
248 Iida H, Tohno M, Islam MA, Sato N, Kobayashi H, Albarracin L, Kober AH, Ikeda-Ohtsubo W, Suda Y, Aso H, Nochi T, Miyazaki A, Uenishi H, Iwabuchi N, Xiao JZ, Villena J, Kitazawa H. Paraimmunobiotic Bifidobacteria Modulate the Expression Patterns of Peptidoglycan Recognition Proteins in Porcine Intestinal Epitheliocytes and Antigen Presenting Cells. Cells 2019;8:E891. [PMID: 31416116 DOI: 10.3390/cells8080891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
249 Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD, Tsatsakis A. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics. Cells 2019;8:E863. [PMID: 31405017 DOI: 10.3390/cells8080863] [Cited by in Crossref: 101] [Cited by in F6Publishing: 109] [Article Influence: 25.3] [Reference Citation Analysis]
250 Rawla P, Barsouk A, Hadjinicolaou AV, Barsouk A. Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer. Med Sci (Basel) 2019;7:E83. [PMID: 31366129 DOI: 10.3390/medsci7080083] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
251 Hekmatshoar Y, Rahbar Saadat Y, Hosseiniyan Khatibi SM, Ozkan T, Zununi Vahed F, Nariman-Saleh-Fam Z, Pourghassem Gargari B, Sunguroglu A, Zununi Vahed S. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental? Life Sci 2019;233:116680. [PMID: 31344431 DOI: 10.1016/j.lfs.2019.116680] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
252 Shi L, Sheng J, Wang M, Luo H, Zhu J, Zhang B, Liu Z, Yang X. Combination Therapy of TGF-β Blockade and Commensal-derived Probiotics Provides Enhanced Antitumor Immune Response and Tumor Suppression. Theranostics. 2019;9:4115-4129. [PMID: 31281535 DOI: 10.7150/thno.35131.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
253 Candido S, Lupo G, Pennisi M, Basile MS, Anfuso CD, Petralia MC, Gattuso G, Vivarelli S, Spandidos DA, Libra M, Falzone L. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease. Oncol Rep 2019;42:911-22. [PMID: 31322245 DOI: 10.3892/or.2019.7215] [Cited by in Crossref: 41] [Cited by in F6Publishing: 58] [Article Influence: 10.3] [Reference Citation Analysis]
254 Teodoro M, Briguglio G, Fenga C, Costa C. Genetic polymorphisms as determinants of pesticide toxicity: Recent advances. Toxicol Rep 2019;6:564-70. [PMID: 31293901 DOI: 10.1016/j.toxrep.2019.06.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
255 Vivarelli S, Falzone L, Basile M, Nicolosi D, Genovese C, Libra M, Salmeri M. Benefits of using probiotics as adjuvants in anticancer therapy (Review). Wrld Acd Sci 2019. [DOI: 10.3892/wasj.2019.13] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
256 Shi L, Sheng J, Wang M, Luo H, Zhu J, Zhang B, Liu Z, Yang X. Combination Therapy of TGF-β Blockade and Commensal-derived Probiotics Provides Enhanced Antitumor Immune Response and Tumor Suppression. Theranostics 2019;9:4115-29. [PMID: 31281535 DOI: 10.7150/thno.35131] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
257 Hofman P, Barlesi F. Companion diagnostic tests for treatment of lung cancer patients: what are the current and future challenges? Expert Review of Molecular Diagnostics 2019;19:429-38. [DOI: 10.1080/14737159.2019.1611426] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
258 Falzone L, Lupo G, La Rosa GRM, Crimi S, Anfuso CD, Salemi R, Rapisarda E, Libra M, Candido S. Identification of Novel MicroRNAs and Their Diagnostic and Prognostic Significance in Oral Cancer. Cancers (Basel) 2019;11:E610. [PMID: 31052345 DOI: 10.3390/cancers11050610] [Cited by in Crossref: 67] [Cited by in F6Publishing: 78] [Article Influence: 16.8] [Reference Citation Analysis]
259 Yuan C, Steer CJ, Subramanian S. Host⁻MicroRNA⁻Microbiota Interactions in Colorectal Cancer. Genes (Basel) 2019;10:E270. [PMID: 30987065 DOI: 10.3390/genes10040270] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
260 Massari F, Mollica V, Di Nunno V, Gatto L, Santoni M, Scarpelli M, Cimadamore A, Lopez-Beltran A, Cheng L, Battelli N, Montironi R, Brandi G. The Human Microbiota and Prostate Cancer: Friend or Foe? Cancers (Basel) 2019;11:E459. [PMID: 30935126 DOI: 10.3390/cancers11040459] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
261 Falzone L, Romano GL, Salemi R, Bucolo C, Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M, Candido S. Prognostic significance of deregulated microRNAs in uveal melanomas. Mol Med Rep 2019;19:2599-610. [PMID: 30816460 DOI: 10.3892/mmr.2019.9949] [Cited by in Crossref: 40] [Cited by in F6Publishing: 59] [Article Influence: 10.0] [Reference Citation Analysis]
262 Falzone L, Libra M, Polesel J. Dietary Inflammatory Index in Ageing and Longevity. Centenarians 2019. [DOI: 10.1007/978-3-030-20762-5_5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
263 Jahani-Sherafat S, Azimirad M, Ghasemian-Safaei H, Ahmadi Amoli H, Moghim S, Sherkat G, Zali MR. The effect of intestinal microbiota metabolites on HT29 cell line using MTT method in patients with colorectal cancer. Gastroenterol Hepatol Bed Bench 2019;12:S74-9. [PMID: 32099605] [Reference Citation Analysis]